Please try another search
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally. The company’s products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs. It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies. The company was founded in 1978 and is headquartered in Xuzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Yulan Li | - | 2022 | Independent Director |
Xinglei Jia | 54 | 2007 | Member of the Supervisory Board |
Ziliang Yang | 59 | 2007 | Deputy GM & Non-Independent Director |
Pengsheng Sun | 65 | 2007 | Non-Independent Chairman of the Board |
Xiao Chen Qian | 60 | 2007 | Employee Representative Member of Supervisory Board |
Qing Fu | 62 | 2007 | Deputy GM & Non-Independent Director |
Fengshou Wang | 62 | 2007 | Chairman of the Supervisory Board |
Jiaquan Sun | 47 | 2010 | GM & Non-Independent Director |
Xiaoxing Yin | 57 | 2022 | Independent Director |
Guoxiang Chen | 58 | 2022 | Independent Director |
Yu Lan Li | 72 | 2022 | Independent Director |
Zengliang Chen | 60 | 2007 | Deputy GM & Non-Independent Director |
Guangji Wang | 70 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review